Skip to main content

Day: October 5, 2022

GFG Increases Previously Announced Private Placement Financing

NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRES SASKATOON, Saskatchewan, Oct. 05, 2022 (GLOBE NEWSWIRE) — GFG Resources Inc. (TSX-V: GFG) (OTCQB: GFGSF) (“GFG” or the “Company”) announces that due to investor demand it has increased the size of its previously announced private placement financing (the “Offering”) (see news release dated August 30, 2022) to an aggregate total of up to C$2.06 million. As part of the current Offering, the Company is pleased to announce that its strategic investor, Alamos Gold Inc. (TSX: AGI; NYSE: AGI) (“Alamos”), has committed to participate in the Offering on a pro-rata basis. The Offering will consist of any combination of (i) units of the Company (“Units”) at a price of C$0.11 per Unit; (ii) common shares of the Company that will qualify as “flow-through shares”...

Continue reading

Ultimovacs Announces Positive Three-Year Results of 71% Overall Survival Rate in Cohort 1 of UV1-103 Study in Metastatic Malignant Melanoma

Malignant melanoma patients treated with immunotherapy combination UV1 and pembrolizumab in phase I clinical trial Consistently high overall survival (OS) rate: 71% at three-year follow-up of patients in first cohort UV1 and pembrolizumab combination continues to demonstrate strong signals of clinical efficacy, including prolonged patient survivalOslo, 5 October 2022: Ultimovacs ASA (“Ultimovacs”) (OSE ULTI), a clinical stage leader in immune stimulatory vaccines for cancer, announced continuing positive efficacy data in its ongoing U.S.-based phase I clinical trial, UV1-103. The study evaluates the Company’s universal cancer vaccine, UV1, in combination with the anti-PD-1 checkpoint inhibitor pembrolizumab, as first-line treatment in advanced non-resectable and metastatic malignant melanoma patients. “Given the historic...

Continue reading

DIGITAL UTILITIES VENTURES, INC. (DUTV) ANNOUNCES THAT THE AVAILABILITY OF $500 MILLION IN USDA GRANTS TO INCREASE INNOVATIVE AMERICAN-MADE FERTILIZER PRODUCTION IS EXPECTED TO INCREASE DEMAND FOR ITS MODULAR “FERTLIZER PLANT IN A BOX”

DIGITAL UTILITIES VENTURES, INC. (DUTV) ANNOUNCES THAT THE AVAILABILITY OF $500 MILLION IN USDA GRANTS TO INCREASE INNOVATIVE AMERICAN-MADE FERTILIZER PRODUCTION USDA announces $500M in grants to boost American fertilizerDIGITAL UTILITIES VENTURES, INC. (DUTV) ANNOUNCES THAT THE AVAILABILITY OF $500 MILLION IN USDA GRANTS TO INCREASE INNOVATIVE AMERICAN-MADE FERTILIZER PRODUCTION Easy FEN Modular Microbe Fertilizer SystemDIGITAL UTILITIES VENTURES, INC. (DUTV) ANNOUNCES THAT THE AVAILABILITY OF $500 MILLION IN USDA GRANTS TO INCREASE INNOVATIVE AMERICAN-MADE FERTILIZER PRODUCTION Easy FEN SystemsDIGITAL UTILITIES VENTURES, INC. (DUTV) ANNOUNCES THAT THE AVAILABILITY OF $500 MILLION IN USDA GRANTS TO INCREASE INNOVATIVE AMERICAN-MADE FERTILIZER PRODUCTION Easy FEN SystemsBoston, Massachusetts, Oct. 05, 2022 (GLOBE NEWSWIRE)...

Continue reading

Company Signs Purchase and Sale Agreement to Acquire Property and Ends Third Quarter Strong

West Palm Beach, FL, Oct. 05, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — Ethema Health Corporation (OTCPINK: GRST) (“Ethema” “GRST” or the “Company”) previously announced that it had entered into an option to purchase the building at 950 Evernia Street, West Palm Beach.  This building is leased by the ARIA subsidiary for its addiction treatment operations.  On October 3, 2022, Ethema signed a purchase and sale agreement (“Agreement”) to purchase the building and paid a $350,000.00 deposit as part of the Agreement, bringing the total deposit to $400,000 after getting credit for the $50,000.00 option payment.  The Agreement has a closing date of January 31, 2023.  The Agreement also provides for a seller’s note which will provide the majority of the balance of funds necessary to close the deal.  The company plans to raise additional...

Continue reading

EDF announces the success of its senior multi-tranche bond issue, including a green tranche, for a nominal amount of 3 billion euros

EDF announces the success of its senior multi-tranche bond issue, including a green tranche, for a nominal amount of 3 billion euros EDF (BBB CW neg S&P / Baa1 neg Moody’s / BBB+ stable Fitch) has successfully launched on 5 October 2022 a senior bond issue in 3 tranches for a nominal amount of 3 billion euros:€750 million Bond, with a long 4-year maturity and a 3.875% fixed coupon; €1 billion Bond, with a 7-year maturity and a 4.375% fixed coupon; €1.25 billion Green Bond, with a 12-year maturity and a 4.75% fixed coupon.An amount equal to the net proceeds of the Green Bond will be used to finance and/or refinance, in whole or in part, electricity distribution investments as defined in EDF’s Green Financing Framework published in July 2022 (1). Settlement and delivery will take place on 12 October 2022, the date on which...

Continue reading

IQST – iQSTEL Restructures Investment Agreement Demonstrating Confidence In Company’s Future

New York, NY, Oct. 05, 2022 (GLOBE NEWSWIRE) — iQSTEL, Inc. (OTCQX: IQST) (“IQST” or the “Company”), today announced the company has amended a common stock purchase option.  “I believe the amended agreement demonstrates the confidence of an important investor has in iQSTEL’s future,” stated iQSTEL CEO Leandro Iglesias. The original stock purchase option was purchased for $500,000 to purchase 4,800,000 shares of common stock at $2 price, the original stock purchase option also included a cashless exercise feature.  The amended agreement has the investor agreeing to forgo the original cashless exercise feature after the first $1,000,000 cashless exercise in addition to committing to cash exercise schedule favorable to iQSTEL. CEO Leandro Iglesias: “I am pleased with the update to the subject investment agreement,...

Continue reading

NFL BIOSCIENCES PARTNERS WITH THEMIS MEDICARE FOR THE DEVELOPMENT OF NFL-101 IN INDIA

NFL BIOSCIENCES PARTNERS WITH THEMIS MEDICARE FOR THE DEVELOPMENT OF NFL-101 IN INDIA NFL BIOSCIENCES (Euronext Growth Paris – FR0014003XT0 – ALNFL), a biopharmaceutical company developing botanical drugs for the treatment of addictions, is announcing that it has entered into a partnership to develop NFL-101, the company’s drug candidate for smoking cessation, for the Indian market with Themis Medicare Ltd (NSE – Symbol: THEMISMED; BSE – Script code: 530199) a Pharmaceutical company headquartered in Mumbai with a legacy of over 50 years of making new treatment options available to patients. Themis Medicare Limited (Themis) submitted an IND (Investigational New Drug) application for a Phase II / III clinical trial to the Central Drugs Standard Control Organization (CDSCO), the National Regulatory Authority of India (NRA). India has...

Continue reading

Quantum Genomics Publishes its 2022 First Half Results and Reviews its Activity

PARIS, Oct. 05, 2022 (GLOBE NEWSWIRE) — Quantum Genomics (Euronext Growth – FR0011648971 – ALQGC), a biopharmaceutical company specialising in the development of a new class of medicinal products that act directly on the brain to treat resistant/difficult to treat hypertension and heart-failure, today published its first half 2022 results. Jean-Philippe Milon, CEO of Quantum Genomics, commented: “Quantum Genomics continues its development trajectory aiming to put a new class of innovative medicinal products on the market. Throughout the past six months, we have concentrated our phase III research programs in the field of difficult to treat or resistant hypertension. In this context, we have enrolled the last patient in the FRESH study. This important step will enable us to soon present the results of this study,...

Continue reading

HashiCorp Extends its Zero Trust Security Solution with Secure Remote Access Delivered in the Cloud

With HCP Boundary, HashiCorp Bolsters its Security Portfolio Built for Cloud Infrastructure Platform Teams LOS ANGELES, Oct. 05, 2022 (GLOBE NEWSWIRE) — HashiCorp, Inc. (NASDAQ: HCP), a leading provider of multi-cloud infrastructure automation software, today announced the general availability of HashiCorp Cloud Platform (HCP) Boundary, a secure remote access product. With this release, Boundary joins HCP Vault and HCP Consul to provide the industry’s first zero trust security solution to secure applications, networks, and people built for the cloud. As organizations move to the cloud and adopt cloud operating models, they require a different approach to security — commonly referred to as zero trust security — where the default security posture is to trust nothing, authenticate and authorize everything. But the gap between legacy...

Continue reading

Verizon Frontline deploys more assets for Hurricane Ian’s first responders

FT. MYERS BEACH, Fla., Oct. 05, 2022 (GLOBE NEWSWIRE) — Verizon Frontline deployed its Tactical Humanitarian Operations Response (THOR) vehicle to one of the areas hardest hit by Hurricane Ian. THOR, the first and only private 5G network-capable mobile emergency operations vehicle of its kind, will augment ongoing support of first responders conducting search, rescue, response and recovery missions in and around Ft. Myers Beach, Fla. Verizon Frontline’s THOR joins more than 100 Verizon and Verizon Frontline assets already in place in Florida to help provide public safety agencies with a reliable connection for mission-critical voice, data and video communications. “THOR is one of hundreds of state-of-the-art Verizon Frontline assets and solutions we have deployed across Lee County in particular, and many of the hardest-hit areas...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.